Maria Masulli

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study

Marilena Vitale, Maria Masulli, Ilaria Calabrese et al. · Nutrients · 2018 · 147 citations · Full text

Obesity, Nutrition, Metabolic Syndrome +15

Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes

Brunella Capaldo, Giovanni Annuzzi, Annalisa Creanza et al. · Diabetes Care · 2020 · 130 citations · Full text

Physical Activity, Cardiometabolic Risk, Artificial Pancreas +19

Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial

Giuseppe Della Pepa, Marco Russo, Marilena Vitale et al. · Diabetes Research and Clinical Practice · 2021 · 79 citations

Metabolic Syndrome, Diabetes Management, Low Dosage +11

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study

Marilena Vitale, Olga Vaccaro, Maria Masulli et al. · Clinical Nutrition · 2016 · 77 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Epidemiology +12